Biomerica (BMRA) Accumulated Expenses (2011 - 2026)

Biomerica has reported Accumulated Expenses for 16 years, with the latest figure at $608000.0 in Q1 2026.

• Quarterly Accumulated Expenses fell 0.65% year-over-year to $608000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $608000.0 (down 0.65% YoY) and the FY2025 annual result came in at $655000.0, up 13.32% from the prior year.
• Accumulated Expenses rose to $608000.0 in Q1 2026 per BMRA's latest filing, from $545000.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $702000.0 in Q1 2024 and troughed at $236000.0 in Q2 2022.
• A 5-year average of $588286.4 and a median of $601000.0 in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses sank 39.32% in 2022, then soared 132.2% in 2023.
• Over 5 years, Accumulated Expenses stood at $697179.0 in 2022, then slipped by 4.19% to $668000.0 in 2023, then retreated by 10.03% to $601000.0 in 2024, then retreated by 9.32% to $545000.0 in 2025, then grew by 11.56% to $608000.0 in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $608000.0, $545000.0, and $591000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.